世界のタンパク質阻害剤市場予測2023-2029:プロテインキナーゼ阻害剤、モノクローナル抗体、その他

【英語タイトル】Protein Inhibitors Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料(MMG23LY8613)・商品コード:MMG23LY8613
・発行会社(調査会社):Market Monitor Global
・発行日:2023年7月
・ページ数:72
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後2-3営業日)
・調査対象地域:グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野:医薬品&ヘルスケア
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD3,250 ⇒換算¥494,000見積依頼/購入/質問フォーム
Multi User(20名様閲覧用)USD4,225 ⇒換算¥642,200見積依頼/購入/質問フォーム
Enterprise User(閲覧人数制限なし)USD4,875 ⇒換算¥741,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・送付(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界のタンパク質阻害剤市場規模と予測を収録しています。・世界のタンパク質阻害剤市場:売上、2018年-2023年、2024年-2029年
・世界のタンパク質阻害剤市場:販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のタンパク質阻害剤市場は2022年に000Mドルと評価され、予測期間中に000%のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「プロテインキナーゼ阻害剤」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

タンパク質阻害剤のグローバル主要企業は、Bayer AG、 Astra Zeneca、 Roche、 Teva、 Apotex、 Novartis、 Glaxosmithkline、 Pfizer、 Boehringer Ingelheim、 F. Hoffmann-La Roche、 Abbott Laboratories、 Amgen Inc.、 Baxter International Inc.などです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL(MMG)は、タンパク質阻害剤のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界のタンパク質阻害剤市場:タイプ別、2018年-2023年、2024年-2029年
世界のタンパク質阻害剤市場:タイプ別市場シェア、2022年
・プロテインキナーゼ阻害剤、モノクローナル抗体、その他

世界のタンパク質阻害剤市場:用途別、2018年-2023年、2024年-2029年
世界のタンパク質阻害剤市場:用途別市場シェア、2022年
・腫瘍、炎症性疾患、その他

世界のタンパク質阻害剤市場:地域・国別、2018年-2023年、2024年-2029年
世界のタンパク質阻害剤市場:地域別市場シェア、2022年
・北米:アメリカ、カナダ、メキシコ
・ヨーロッパ:ドイツ、フランス、イギリス、イタリア、ロシア
・アジア:中国、日本、韓国、東南アジア、インド
・南米:ブラジル、アルゼンチン
・中東・アフリカ:トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業におけるタンパク質阻害剤のグローバル売上、2018年-2023年
・主要企業におけるタンパク質阻害剤のグローバル売上シェア、2022年
・主要企業におけるタンパク質阻害剤のグローバル販売量、2018年-2023年
・主要企業におけるタンパク質阻害剤のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Bayer AG、 Astra Zeneca、 Roche、 Teva、 Apotex、 Novartis、 Glaxosmithkline、 Pfizer、 Boehringer Ingelheim、 F. Hoffmann-La Roche、 Abbott Laboratories、 Amgen Inc.、 Baxter International Inc.

*************************************************************

・調査・分析レポートの概要
タンパク質阻害剤市場の定義
市場セグメント
世界のタンパク質阻害剤市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のタンパク質阻害剤市場規模
世界のタンパク質阻害剤市場規模:2022年 VS 2029年
世界のタンパク質阻害剤市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのタンパク質阻害剤の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のタンパク質阻害剤製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分:プロテインキナーゼ阻害剤、モノクローナル抗体、その他
タンパク質阻害剤のタイプ別グローバル売上・予測

・用途別市場分析
用途区分:腫瘍、炎症性疾患、その他
タンパク質阻害剤の用途別グローバル売上・予測

・地域別市場分析
地域別タンパク質阻害剤市場規模 2022年と2029年
地域別タンパク質阻害剤売上・予測
北米市場:アメリカ、カナダ、メキシコ
ヨーロッパ市場:ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場:中国、日本、韓国、東南アジア、インド
南米市場:ブラジル、アルゼンチン
中東・アフリカ市場:トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル(企業概要、事業概要、主要製品、売上、ニュースなど)
Bayer AG、 Astra Zeneca、 Roche、 Teva、 Apotex、 Novartis、 Glaxosmithkline、 Pfizer、 Boehringer Ingelheim、 F. Hoffmann-La Roche、 Abbott Laboratories、 Amgen Inc.、 Baxter International Inc.
...

This report aims to provide a comprehensive presentation of the global market for Protein Inhibitors, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Protein Inhibitors. This report contains market size and forecasts of Protein Inhibitors in global, including the following market information:
Global Protein Inhibitors Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Protein Inhibitors Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Protein Inhibitors companies in 2022 (%)
The global Protein Inhibitors market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Protein Kinase Inhibitors Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Protein Inhibitors include Bayer AG, Astra Zeneca, Roche, Teva, Apotex, Novartis, Glaxosmithkline, Pfizer and Boehringer Ingelheim, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Protein Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Protein Inhibitors Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Protein Inhibitors Market Segment Percentages, by Type, 2022 (%)
Protein Kinase Inhibitors
Monoclonal Antibody
Others
Global Protein Inhibitors Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Protein Inhibitors Market Segment Percentages, by Application, 2022 (%)
Oncology
Inflamatory Diseases
Others
Global Protein Inhibitors Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Protein Inhibitors Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Protein Inhibitors revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Protein Inhibitors revenues share in global market, 2022 (%)
Key companies Protein Inhibitors sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Protein Inhibitors sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer AG
Astra Zeneca
Roche
Teva
Apotex
Novartis
Glaxosmithkline
Pfizer
Boehringer Ingelheim
F. Hoffmann-La Roche
Abbott Laboratories
Amgen Inc.
Baxter International Inc.
Outline of Major Chapters:
Chapter 1: Introduces the definition of Protein Inhibitors, market overview.
Chapter 2: Global Protein Inhibitors market size in revenue and volume.
Chapter 3: Detailed analysis of Protein Inhibitors manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Protein Inhibitors in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Protein Inhibitors capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Protein Inhibitors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Protein Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Protein Inhibitors Overall Market Size
2.1 Global Protein Inhibitors Market Size: 2022 VS 2029
2.2 Global Protein Inhibitors Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Protein Inhibitors Sales: 2018-2029
3 Company Landscape
3.1 Top Protein Inhibitors Players in Global Market
3.2 Top Global Protein Inhibitors Companies Ranked by Revenue
3.3 Global Protein Inhibitors Revenue by Companies
3.4 Global Protein Inhibitors Sales by Companies
3.5 Global Protein Inhibitors Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Protein Inhibitors Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Protein Inhibitors Product Type
3.8 Tier 1, Tier 2 and Tier 3 Protein Inhibitors Players in Global Market
3.8.1 List of Global Tier 1 Protein Inhibitors Companies
3.8.2 List of Global Tier 2 and Tier 3 Protein Inhibitors Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Protein Inhibitors Market Size Markets, 2022 & 2029
4.1.2 Protein Kinase Inhibitors
4.1.3 Monoclonal Antibody
4.1.4 Others
4.2 By Type – Global Protein Inhibitors Revenue & Forecasts
4.2.1 By Type – Global Protein Inhibitors Revenue, 2018-2023
4.2.2 By Type – Global Protein Inhibitors Revenue, 2024-2029
4.2.3 By Type – Global Protein Inhibitors Revenue Market Share, 2018-2029
4.3 By Type – Global Protein Inhibitors Sales & Forecasts
4.3.1 By Type – Global Protein Inhibitors Sales, 2018-2023
4.3.2 By Type – Global Protein Inhibitors Sales, 2024-2029
4.3.3 By Type – Global Protein Inhibitors Sales Market Share, 2018-2029
4.4 By Type – Global Protein Inhibitors Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Protein Inhibitors Market Size, 2022 & 2029
5.1.2 Oncology
5.1.3 Inflamatory Diseases
5.1.4 Others
5.2 By Application – Global Protein Inhibitors Revenue & Forecasts
5.2.1 By Application – Global Protein Inhibitors Revenue, 2018-2023
5.2.2 By Application – Global Protein Inhibitors Revenue, 2024-2029
5.2.3 By Application – Global Protein Inhibitors Revenue Market Share, 2018-2029
5.3 By Application – Global Protein Inhibitors Sales & Forecasts
5.3.1 By Application – Global Protein Inhibitors Sales, 2018-2023
5.3.2 By Application – Global Protein Inhibitors Sales, 2024-2029
5.3.3 By Application – Global Protein Inhibitors Sales Market Share, 2018-2029
5.4 By Application – Global Protein Inhibitors Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Protein Inhibitors Market Size, 2022 & 2029
6.2 By Region – Global Protein Inhibitors Revenue & Forecasts
6.2.1 By Region – Global Protein Inhibitors Revenue, 2018-2023
6.2.2 By Region – Global Protein Inhibitors Revenue, 2024-2029
6.2.3 By Region – Global Protein Inhibitors Revenue Market Share, 2018-2029
6.3 By Region – Global Protein Inhibitors Sales & Forecasts
6.3.1 By Region – Global Protein Inhibitors Sales, 2018-2023
6.3.2 By Region – Global Protein Inhibitors Sales, 2024-2029
6.3.3 By Region – Global Protein Inhibitors Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Protein Inhibitors Revenue, 2018-2029
6.4.2 By Country – North America Protein Inhibitors Sales, 2018-2029
6.4.3 US Protein Inhibitors Market Size, 2018-2029
6.4.4 Canada Protein Inhibitors Market Size, 2018-2029
6.4.5 Mexico Protein Inhibitors Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Protein Inhibitors Revenue, 2018-2029
6.5.2 By Country – Europe Protein Inhibitors Sales, 2018-2029
6.5.3 Germany Protein Inhibitors Market Size, 2018-2029
6.5.4 France Protein Inhibitors Market Size, 2018-2029
6.5.5 U.K. Protein Inhibitors Market Size, 2018-2029
6.5.6 Italy Protein Inhibitors Market Size, 2018-2029
6.5.7 Russia Protein Inhibitors Market Size, 2018-2029
6.5.8 Nordic Countries Protein Inhibitors Market Size, 2018-2029
6.5.9 Benelux Protein Inhibitors Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Protein Inhibitors Revenue, 2018-2029
6.6.2 By Region – Asia Protein Inhibitors Sales, 2018-2029
6.6.3 China Protein Inhibitors Market Size, 2018-2029
6.6.4 Japan Protein Inhibitors Market Size, 2018-2029
6.6.5 South Korea Protein Inhibitors Market Size, 2018-2029
6.6.6 Southeast Asia Protein Inhibitors Market Size, 2018-2029
6.6.7 India Protein Inhibitors Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Protein Inhibitors Revenue, 2018-2029
6.7.2 By Country – South America Protein Inhibitors Sales, 2018-2029
6.7.3 Brazil Protein Inhibitors Market Size, 2018-2029
6.7.4 Argentina Protein Inhibitors Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Protein Inhibitors Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Protein Inhibitors Sales, 2018-2029
6.8.3 Turkey Protein Inhibitors Market Size, 2018-2029
6.8.4 Israel Protein Inhibitors Market Size, 2018-2029
6.8.5 Saudi Arabia Protein Inhibitors Market Size, 2018-2029
6.8.6 UAE Protein Inhibitors Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Bayer AG
7.1.1 Bayer AG Company Summary
7.1.2 Bayer AG Business Overview
7.1.3 Bayer AG Protein Inhibitors Major Product Offerings
7.1.4 Bayer AG Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.1.5 Bayer AG Key News & Latest Developments
7.2 Astra Zeneca
7.2.1 Astra Zeneca Company Summary
7.2.2 Astra Zeneca Business Overview
7.2.3 Astra Zeneca Protein Inhibitors Major Product Offerings
7.2.4 Astra Zeneca Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.2.5 Astra Zeneca Key News & Latest Developments
7.3 Roche
7.3.1 Roche Company Summary
7.3.2 Roche Business Overview
7.3.3 Roche Protein Inhibitors Major Product Offerings
7.3.4 Roche Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.3.5 Roche Key News & Latest Developments
7.4 Teva
7.4.1 Teva Company Summary
7.4.2 Teva Business Overview
7.4.3 Teva Protein Inhibitors Major Product Offerings
7.4.4 Teva Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.4.5 Teva Key News & Latest Developments
7.5 Apotex
7.5.1 Apotex Company Summary
7.5.2 Apotex Business Overview
7.5.3 Apotex Protein Inhibitors Major Product Offerings
7.5.4 Apotex Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.5.5 Apotex Key News & Latest Developments
7.6 Novartis
7.6.1 Novartis Company Summary
7.6.2 Novartis Business Overview
7.6.3 Novartis Protein Inhibitors Major Product Offerings
7.6.4 Novartis Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.6.5 Novartis Key News & Latest Developments
7.7 Glaxosmithkline
7.7.1 Glaxosmithkline Company Summary
7.7.2 Glaxosmithkline Business Overview
7.7.3 Glaxosmithkline Protein Inhibitors Major Product Offerings
7.7.4 Glaxosmithkline Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.7.5 Glaxosmithkline Key News & Latest Developments
7.8 Pfizer
7.8.1 Pfizer Company Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer Protein Inhibitors Major Product Offerings
7.8.4 Pfizer Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.8.5 Pfizer Key News & Latest Developments
7.9 Boehringer Ingelheim
7.9.1 Boehringer Ingelheim Company Summary
7.9.2 Boehringer Ingelheim Business Overview
7.9.3 Boehringer Ingelheim Protein Inhibitors Major Product Offerings
7.9.4 Boehringer Ingelheim Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.9.5 Boehringer Ingelheim Key News & Latest Developments
7.10 F. Hoffmann-La Roche
7.10.1 F. Hoffmann-La Roche Company Summary
7.10.2 F. Hoffmann-La Roche Business Overview
7.10.3 F. Hoffmann-La Roche Protein Inhibitors Major Product Offerings
7.10.4 F. Hoffmann-La Roche Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.10.5 F. Hoffmann-La Roche Key News & Latest Developments
7.11 Abbott Laboratories
7.11.1 Abbott Laboratories Company Summary
7.11.2 Abbott Laboratories Protein Inhibitors Business Overview
7.11.3 Abbott Laboratories Protein Inhibitors Major Product Offerings
7.11.4 Abbott Laboratories Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.11.5 Abbott Laboratories Key News & Latest Developments
7.12 Amgen Inc.
7.12.1 Amgen Inc. Company Summary
7.12.2 Amgen Inc. Protein Inhibitors Business Overview
7.12.3 Amgen Inc. Protein Inhibitors Major Product Offerings
7.12.4 Amgen Inc. Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.12.5 Amgen Inc. Key News & Latest Developments
7.13 Baxter International Inc.
7.13.1 Baxter International Inc. Company Summary
7.13.2 Baxter International Inc. Protein Inhibitors Business Overview
7.13.3 Baxter International Inc. Protein Inhibitors Major Product Offerings
7.13.4 Baxter International Inc. Protein Inhibitors Sales and Revenue in Global (2018-2023)
7.13.5 Baxter International Inc. Key News & Latest Developments
8 Global Protein Inhibitors Production Capacity, Analysis
8.1 Global Protein Inhibitors Production Capacity, 2018-2029
8.2 Protein Inhibitors Production Capacity of Key Manufacturers in Global Market
8.3 Global Protein Inhibitors Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Protein Inhibitors Supply Chain Analysis
10.1 Protein Inhibitors Industry Value Chain
10.2 Protein Inhibitors Upstream Market
10.3 Protein Inhibitors Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Protein Inhibitors Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Protein Inhibitors in Global Market
Table 2. Top Protein Inhibitors Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Protein Inhibitors Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Protein Inhibitors Revenue Share by Companies, 2018-2023
Table 5. Global Protein Inhibitors Sales by Companies, (K Units), 2018-2023
Table 6. Global Protein Inhibitors Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Protein Inhibitors Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Protein Inhibitors Product Type
Table 9. List of Global Tier 1 Protein Inhibitors Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Protein Inhibitors Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Protein Inhibitors Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Protein Inhibitors Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Protein Inhibitors Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Protein Inhibitors Sales (K Units), 2018-2023
Table 15. By Type - Global Protein Inhibitors Sales (K Units), 2024-2029
Table 16. By Application – Global Protein Inhibitors Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Protein Inhibitors Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Protein Inhibitors Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Protein Inhibitors Sales (K Units), 2018-2023
Table 20. By Application - Global Protein Inhibitors Sales (K Units), 2024-2029
Table 21. By Region – Global Protein Inhibitors Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Protein Inhibitors Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Protein Inhibitors Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Protein Inhibitors Sales (K Units), 2018-2023
Table 25. By Region - Global Protein Inhibitors Sales (K Units), 2024-2029
Table 26. By Country - North America Protein Inhibitors Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Protein Inhibitors Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Protein Inhibitors Sales, (K Units), 2018-2023
Table 29. By Country - North America Protein Inhibitors Sales, (K Units), 2024-2029
Table 30. By Country - Europe Protein Inhibitors Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Protein Inhibitors Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Protein Inhibitors Sales, (K Units), 2018-2023
Table 33. By Country - Europe Protein Inhibitors Sales, (K Units), 2024-2029
Table 34. By Region - Asia Protein Inhibitors Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Protein Inhibitors Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Protein Inhibitors Sales, (K Units), 2018-2023
Table 37. By Region - Asia Protein Inhibitors Sales, (K Units), 2024-2029
Table 38. By Country - South America Protein Inhibitors Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Protein Inhibitors Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Protein Inhibitors Sales, (K Units), 2018-2023
Table 41. By Country - South America Protein Inhibitors Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Protein Inhibitors Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Protein Inhibitors Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Protein Inhibitors Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Protein Inhibitors Sales, (K Units), 2024-2029
Table 46. Bayer AG Company Summary
Table 47. Bayer AG Protein Inhibitors Product Offerings
Table 48. Bayer AG Protein Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Bayer AG Key News & Latest Developments
Table 50. Astra Zeneca Company Summary
Table 51. Astra Zeneca Protein Inhibitors Product Offerings
Table 52. Astra Zeneca Protein Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Astra Zeneca Key News & Latest Developments
Table 54. Roche Company Summary
Table 55. Roche Protein Inhibitors Product Offerings
Table 56. Roche Protein Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Roche Key News & Latest Developments
Table 58. Teva Company Summary
Table 59. Teva Protein Inhibitors Product Offerings
Table 60. Teva Protein Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Teva Key News & Latest Developments
Table 62. Apotex Company Summary
Table 63. Apotex Protein Inhibitors Product Offerings
Table 64. Apotex Protein Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Apotex Key News & Latest Developments
Table 66. Novartis Company Summary
Table 67. Novartis Protein Inhibitors Product Offerings
Table 68. Novartis Protein Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Novartis Key News & Latest Developments
Table 70. Glaxosmithkline Company Summary
Table 71. Glaxosmithkline Protein Inhibitors Product Offerings
Table 72. Glaxosmithkline Protein Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Glaxosmithkline Key News & Latest Developments
Table 74. Pfizer Company Summary
Table 75. Pfizer Protein Inhibitors Product Offerings
Table 76. Pfizer Protein Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Pfizer Key News & Latest Developments
Table 78. Boehringer Ingelheim Company Summary
Table 79. Boehringer Ingelheim Protein Inhibitors Product Offerings
Table 80. Boehringer Ingelheim Protein Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 81. Boehringer Ingelheim Key News & Latest Developments
Table 82. F. Hoffmann-La Roche Company Summary
Table 83. F. Hoffmann-La Roche Protein Inhibitors Product Offerings
Table 84. F. Hoffmann-La Roche Protein Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 85. F. Hoffmann-La Roche Key News & Latest Developments
Table 86. Abbott Laboratories Company Summary
Table 87. Abbott Laboratories Protein Inhibitors Product Offerings
Table 88. Abbott Laboratories Protein Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 89. Abbott Laboratories Key News & Latest Developments
Table 90. Amgen Inc. Company Summary
Table 91. Amgen Inc. Protein Inhibitors Product Offerings
Table 92. Amgen Inc. Protein Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 93. Amgen Inc. Key News & Latest Developments
Table 94. Baxter International Inc. Company Summary
Table 95. Baxter International Inc. Protein Inhibitors Product Offerings
Table 96. Baxter International Inc. Protein Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 97. Baxter International Inc. Key News & Latest Developments
Table 98. Protein Inhibitors Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 99. Global Protein Inhibitors Capacity Market Share of Key Manufacturers, 2021-2023
Table 100. Global Protein Inhibitors Production by Region, 2018-2023 (K Units)
Table 101. Global Protein Inhibitors Production by Region, 2024-2029 (K Units)
Table 102. Protein Inhibitors Market Opportunities & Trends in Global Market
Table 103. Protein Inhibitors Market Drivers in Global Market
Table 104. Protein Inhibitors Market Restraints in Global Market
Table 105. Protein Inhibitors Raw Materials
Table 106. Protein Inhibitors Raw Materials Suppliers in Global Market
Table 107. Typical Protein Inhibitors Downstream
Table 108. Protein Inhibitors Downstream Clients in Global Market
Table 109. Protein Inhibitors Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Protein Inhibitors Segment by Type in 2022
Figure 2. Protein Inhibitors Segment by Application in 2022
Figure 3. Global Protein Inhibitors Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Protein Inhibitors Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Protein Inhibitors Revenue, 2018-2029 (US$, Mn)
Figure 7. Protein Inhibitors Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Protein Inhibitors Revenue in 2022
Figure 9. By Type - Global Protein Inhibitors Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Protein Inhibitors Revenue Market Share, 2018-2029
Figure 11. By Type - Global Protein Inhibitors Sales Market Share, 2018-2029
Figure 12. By Type - Global Protein Inhibitors Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Protein Inhibitors Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Protein Inhibitors Revenue Market Share, 2018-2029
Figure 15. By Application - Global Protein Inhibitors Sales Market Share, 2018-2029
Figure 16. By Application - Global Protein Inhibitors Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Protein Inhibitors Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Protein Inhibitors Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Protein Inhibitors Revenue Market Share, 2018-2029
Figure 20. By Region - Global Protein Inhibitors Sales Market Share, 2018-2029
Figure 21. By Country - North America Protein Inhibitors Revenue Market Share, 2018-2029
Figure 22. By Country - North America Protein Inhibitors Sales Market Share, 2018-2029
Figure 23. US Protein Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Protein Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Protein Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Protein Inhibitors Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Protein Inhibitors Sales Market Share, 2018-2029
Figure 28. Germany Protein Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 29. France Protein Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Protein Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Protein Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Protein Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Protein Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Protein Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Protein Inhibitors Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Protein Inhibitors Sales Market Share, 2018-2029
Figure 37. China Protein Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Protein Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Protein Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Protein Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 41. India Protein Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Protein Inhibitors Revenue Market Share, 2018-2029
Figure 43. By Country - South America Protein Inhibitors Sales Market Share, 2018-2029
Figure 44. Brazil Protein Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Protein Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Protein Inhibitors Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Protein Inhibitors Sales Market Share, 2018-2029
Figure 48. Turkey Protein Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Protein Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Protein Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Protein Inhibitors Revenue, (US$, Mn), 2018-2029
Figure 52. Global Protein Inhibitors Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Protein Inhibitors by Region, 2022 VS 2029
Figure 54. Protein Inhibitors Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界のタンパク質阻害剤市場予測2023-2029:プロテインキナーゼ阻害剤、モノクローナル抗体、その他] (コード:MMG23LY8613)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のタンパク質阻害剤市場予測2023-2029:プロテインキナーゼ阻害剤、モノクローナル抗体、その他]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆